Kymera Therapeutics, Inc. (KYMR)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

300 TECHNOLOGY SQUARE CAMBRIDGE, MA 02139

Kymera Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. Kymera Therapeutics serves customers in the State of Massachusetts.

Data as of 2021-05-08 12:11:55 -0400
Market Cap1.984 Billion Shares Outstanding45.03 Million Avg 30-day Volume363.396 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-41.5 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low91.92 / 25.43 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from KYMR instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 1 200.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 76 52 46.15% 24 (1.44%) 27 (1.68%) -11.11%
13F shares: 19.597 Million 16.814 Million 16.55% 10.806 Million 11.466 Million -5.75%
% Ownership 44.08 37.8203 16.55% 24.3056 25.789 -5.75%
New Positions: 39 51 -23.53% 7 27 -74.07%
Increased Positions 13 6
Closed Positions 16 11
Reduced Positions 13 7
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding KYMR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KYMR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

545.2 Thousand total shares from 15 transactions

Exercise Derivative Conversion (M)

112 Thousand total shares from 13 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MAINOLFI NELLO CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,871,988 2021-04-22 5

JACOBS BRUCE N. CHIEF FINANCIAL OFFICER

  • Officer
236,899 2021-04-13 5

BOOTH BRUCE

  • Director
7,998,317 2021-03-12 2

RIDLOFF ELENA

  • Director
0 2021-03-12 2

ATLAS VENTURE ASSOCIATES X, L.P.

ATLAS VENTURE ASSOCIATES X, LLC

  • 10% Owner
6,885,631 2021-03-12 1

GOLLOB JARED CHIEF MEDICAL OFFICER

  • Officer
215,413 2021-03-11 4

CHESWORTH RICHARD CHIEF SCIENTIFIC OFFICER

  • Officer
60,000 2021-03-01 1

ATLAS VENTURE FUND X, L.P.

  • 10% Owner
6,885,631 2021-02-18 2

ESPOSITO PAMELA

  • Director
0 2020-09-04 2

HALL STEVEN EDWARD

  • Director
2,192,249 2020-08-25 1

REDMILE GROUP, LLC

GREEN JEREMY

  • 10% Owner
1,630,660 2020-08-25 1

ALEXANDRIA VENTURE INVESTMENTS, LLC

  • 10% Owner
467,932 2020-08-25 1

ATLAS VENTURE FUND X, L.P.

ATLAS VENTURE ASSOCIATES X, LLC

ATLAS VENTURE ASSOCIATES X, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

ATLAS VENTURE OPPORTUNITY FUND I, L.P.

  • 10% Owner
9,061,668 2020-08-25 2

WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P.

  • 10% Owner
959,211 2020-08-25 1

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BVF I GP LLC

BIOTECHNOLOGY VALUE FUND II LP

BVF II GP LLC

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF GP HOLDINGS LLC

BVF INC/IL

LAMPERT MARK N

  • Director
  • SEE REMARKSSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
181,081 2020-08-20 2

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-26 17:15:55 -0400 2021-04-26 M 2,768 $2.08 a 399,967 direct 6.9613 -0.689 8.5769 3 -0.689 6

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-26 17:15:55 -0400 2021-04-26 M 2,768 d 224,725 direct

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-26 17:15:55 -0400 2021-04-26 S 2,768 $40.18 d 397,199 direct yes 6.9613 -0.689 8.5769 3 -0.689 6

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-26 17:15:55 -0400 2021-04-23 M 680 d 227,493 direct

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-26 17:15:55 -0400 2021-04-23 S 680 $40.01 d 397,199 direct yes 6.9613 -0.689 8.5769 3 -0.689 6

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-26 17:15:55 -0400 2021-04-23 M 680 $2.08 a 397,879 direct 6.9613 -0.689 8.5769 3 -0.689 6

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-26 17:15:55 -0400 2021-04-22 S 10,959 $40.26 d 397,199 direct yes 6.9613 -0.689 8.5769 3 -0.689 6

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-26 17:15:55 -0400 2021-04-22 M 10,959 d 228,173 direct

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-26 17:15:55 -0400 2021-04-22 M 10,959 $2.08 a 408,158 direct 6.9613 -0.689 8.5769 3 -0.689 6

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-19 19:12:16 -0400 2021-04-19 M 6,000 d 151,424 direct

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-19 19:12:16 -0400 2021-04-19 M 6,000 $2.08 a 397,199 direct -0.1255 5.6476 5.6476 6 -4.7691 4

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-19 19:12:16 -0400 2021-04-19 M 653 d 239,132 direct

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-19 19:12:16 -0400 2021-04-19 S 653 $40.00 d 391,199 direct yes -0.1255 5.6476 5.6476 6 -4.7691 4

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-19 19:12:16 -0400 2021-04-19 M 653 $2.08 a 391,852 direct -0.1255 5.6476 5.6476 6 -4.7691 4

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-19 19:12:16 -0400 2021-04-15 S 4,940 $40.29 d 391,199 direct yes -0.1255 5.6476 5.6476 6 -4.7691 4

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-19 19:12:16 -0400 2021-04-15 M 4,940 $2.08 a 396,139 direct -0.1255 5.6476 5.6476 6 -4.7691 4

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-19 19:12:16 -0400 2021-04-15 M 4,940 d 239,785 direct

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-13 18:39:33 -0400 2021-04-13 M 15,000 $2.08 a 391,199 direct 6.2552 9.6445 9.7823 5 0.0 1

JACOBS BRUCE N. - Officer CHIEF FINANCIAL OFFICER

2021-04-13 18:37:04 -0400 2021-04-13 M 7,000 d 229,899 direct

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-13 18:39:33 -0400 2021-04-13 M 15,000 d 157,424 direct

JACOBS BRUCE N. - Officer CHIEF FINANCIAL OFFICER

2021-04-13 18:37:04 -0400 2021-04-13 M 7,000 $2.08 a 7,000 direct 6.2552 9.6445 9.7823 5 0.0 1

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-12 18:11:37 -0400 2021-04-12 M 15,267 d 244,725 direct

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-12 18:11:37 -0400 2021-04-12 S 4,905 $33.32 d 376,199 direct yes 16.7632 28.1853 28.1853 6 0.0 1

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-12 18:11:37 -0400 2021-04-12 S 10,362 $32.29 d 381,104 direct yes 16.7632 28.1853 28.1853 6 0.0 1

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-12 18:11:37 -0400 2021-04-12 M 15,267 $2.08 a 391,466 direct 16.7632 28.1853 28.1853 6 0.0 1

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-12 18:11:37 -0400 2021-04-09 S 3,742 $34.19 d 376,199 direct yes 16.7632 28.1853 28.1853 6 0.0 1

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-12 18:11:37 -0400 2021-04-09 M 22,794 d 259,992 direct

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-12 18:11:37 -0400 2021-04-09 S 19,052 $33.58 d 379,941 direct yes 16.7632 28.1853 28.1853 6 0.0 1

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-12 18:11:37 -0400 2021-04-09 M 22,794 $2.08 a 398,993 direct 16.7632 28.1853 28.1853 6 0.0 1

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-12 18:11:37 -0400 2021-04-08 S 2,323 $35.62 d 376,199 direct yes 16.7632 28.1853 28.1853 6 0.0 1

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-12 18:11:37 -0400 2021-04-08 S 7,616 $34.81 d 378,522 direct yes 16.7632 28.1853 28.1853 6 0.0 1

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-12 18:11:37 -0400 2021-04-08 M 9,939 d 282,786 direct

MAINOLFI NELLO - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-12 18:11:37 -0400 2021-04-08 M 9,939 $2.08 a 386,138 direct 16.7632 28.1853 28.1853 6 0.0 1

JACOBS BRUCE N. - Officer CHIEF FINANCIAL OFFICER

2021-03-15 21:08:10 -0400 2021-03-15 M 8,195 $2.08 a 8,195 direct -2.0968 -23.2867 -23.2526 0.0 1 -47.0167 20

GOLLOB JARED - Officer CHIEF MEDICAL OFFICER

2021-03-15 21:12:02 -0400 2021-03-15 M 7,800 d 60,007 direct

JACOBS BRUCE N. - Officer CHIEF FINANCIAL OFFICER

2021-03-15 21:08:10 -0400 2021-03-15 M 8,195 d 234,061 direct

GOLLOB JARED - Officer CHIEF MEDICAL OFFICER

2021-03-15 21:12:02 -0400 2021-03-15 S 10,305 $60.17 d 42,547 direct yes -2.0968 -23.2867 -23.2526 0.0 1 -47.0167 20

JACOBS BRUCE N. - Officer CHIEF FINANCIAL OFFICER

2021-03-15 21:08:10 -0400 2021-03-15 S 8,195 $60.17 d 0 direct yes -2.0968 -23.2867 -23.2526 0.0 1 -47.0167 20

GOLLOB JARED - Officer CHIEF MEDICAL OFFICER

2021-03-15 21:12:02 -0400 2021-03-15 M 7,800 $1.31 a 52,852 direct -2.0968 -23.2867 -23.2526 0.0 1 -47.0167 20

BOOTH BRUCE - Director see footnote

2021-03-16 19:39:10 -0400 2021-03-12 S 229,350 $56.50 d 0 indirect -13.9474 -28.6087 -20.4249 0.0 1 -45.8819 19

ATLAS VENTURE ASSOCIATES X, L.P. - > 10% Owner

ATLAS VENTURE ASSOCIATES X, LLC - > 10% Owner

2021-03-16 19:37:24 -0400 2021-03-12 S 229,350 $56.50 d 0 direct -13.9474 -28.6087 -20.4249 0.0 1 -45.8819 19

RIDLOFF ELENA - Director

2021-03-16 17:22:19 -0400 2021-03-12 A 40,127 a 40,127 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
KYMERA THERAPEUTICS INC KYMR 2021-05-10 22:15:04 UTC -0.3607 0.4107 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 21:45:02 UTC -0.3607 0.4107 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 21:15:02 UTC -0.3607 0.4107 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 20:45:03 UTC -0.3622 0.4122 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 20:15:03 UTC -0.3622 0.4122 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 19:45:03 UTC -0.3622 0.4122 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 19:15:03 UTC -0.3622 0.4122 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 18:45:03 UTC -0.3608 0.4108 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 18:15:03 UTC -0.3608 0.4108 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 17:45:02 UTC -0.3608 0.4108 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 17:15:03 UTC -0.3608 0.4108 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 16:45:03 UTC -0.3769 0.4269 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 16:15:03 UTC -0.3769 0.4269 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 15:45:03 UTC -0.3769 0.4269 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 15:15:03 UTC -0.3769 0.4269 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 14:45:04 UTC -0.3873 0.4373 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 14:15:04 UTC -0.3873 0.4373 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 13:45:04 UTC -0.3873 0.4373 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 13:15:03 UTC -0.3873 0.4373 55000
KYMERA THERAPEUTICS INC KYMR 2021-05-10 12:45:02 UTC -0.3873 0.4373 55000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund KYMR -100.0 shares, $-3886.0 2021-03-31 N-PORT

Elevate your investments